(Q53104667)

11 May 2018

title

Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer. (English)

1 reference

11 May 2018

7

Gi Jeong Cheon

1 reference

11 May 2018

author name string

Hyun Hoon Chung

1

1 reference

11 May 2018

Inki Lee

2

1 reference

11 May 2018

Hee Seung Kim

3

1 reference

11 May 2018

Jae Weon Kim

4

1 reference

11 May 2018

Noh-Hyun Park

5

1 reference

11 May 2018

Yong Sang Song

6

1 reference

11 May 2018

language of work or name

English

0 references

publication date

20 June 2013

1 reference

11 May 2018

published in

Gynecologic Oncology

1 reference

11 May 2018

volume

130

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

446-451

1 reference

11 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

7 January 2021

Endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Multivariate survival analysis of the patients with recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prognosis and treatment of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prognostic significance of gross myometrial invasion with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Comparative Performance of the 2009 International Federation of Gynecology and Obstetricsʼ Staging System for Uterine Corpus Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

PET/CT in gynecologic cancer: present applications and future prospects--a clinician's perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Metabolic tumor volume by 18F-FDG PET/CT is prognostic for stage IVB endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Time-dependent ROC curves for censored survival data and a diagnostic marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prognostic significance of SUVmax (maximum standardized uptake value) measured by [¹⁸F]FDG PET/CT in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

FDG PET for the assessment of myometrial infiltration in clinical stage I uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Post-treatment [¹⁸F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Metabolic tumor burden predicts for disease progression and death in lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.06.021

10.1016/J.YGYNO.2013.06.021

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018